Drag

Sanofi India Limited

Healthcare SANOFI

4017.70INR
-50.60 ( -1.24%)

Last update at 2026-01-30 15:58:06

Day Range

4001.104070.00
LowHigh

52 Week Range

4051.00 6493.13
LowHigh

Fundamentals

  • Previous Close 4068.30
  • Market Cap 95811.08M
  • Volume22,312
  • P/E Ratio 26.88
  • EBITDA 5176.50M
  • Revenue TTM 19325.00M
  • Revenue Per Share TTM 839.08
  • Gross Profit TTM 9787.00M
  • Diluted EPS TTM 154.75

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Income before tax 4314.00M 5285.00M 8643.00M 12576.00M 6772.00M
Net income 4133.00M 6029.00M 6206.00M 9444.00M 4776.00M
Total Revenue 20132.00M 19961.00M 27701.00M 29246.00M 28688.00M
Gross Profit 10190.00M 10310.00M 15805.00M 16178.00M 16152.00M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 16118.00M 17148.00M 20717.00M 30610.00M 29185.00M
Intangible assets 13.00M 75.00M 51.00M 52.00M 381.00M
Other current assets 105.00M 487.00M 463.00M 34.00M 28.00M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Change in Cash -1107.00M -6104.00M -5331.00M 3406.00M 775.00M
Operating Cash 4615.00M 2304.00M 3987.00M 5588.00M 6111.00M
Free Cash Flow 4251.00M 1961.00M 3765.00M 5358.00M 5697.00M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - General

Company Change Price Market Cap (M) P/E Ratio
SANOFI
Sanofi India Limited 		-50.60 -1.24% 4017.70 95811.08 26.88
GLAXO
GlaxoSmithKline Pharmaceuticals Limited 		-22.40 -0.92% 2412.90 406354.23 42.58
PFIZER
Pfizer Limited 		83.80 1.80% 4751.40 222237.90 26.50
SANOFICONR
SANOFI CONS HEALTHC IND L 		-97.90 -2.23% 4291.00 101612.67 46.61
MARKSANS
Marksans Pharma Limited 		-2.46 -1.37% 177.58 81052.87 23.02

Profile

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products to approximately 24 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

Sanofi India Limited

Sanofi House, Mumbai, India, 400072

Key Executives

Name Title Year Born
Mr. Vaibhav Karandikar CFO & Additional Whole Time Director 1973
Ms. Radhika Shah Company Sec., Compliance Officer & Nodal Officer NA
Mr. Cherian Mathew Head of Manufacturing Operations & Additional Whole Time Director 1965
Mr. Rodolfo Hrosz MD & Director NA
Mr. M. K. Narayanaswamy B.Com.,A.I.C.W.A. Sr. Director of Accounting & Taxation 1955
Ms. J. Yasmin Cama Sr. Director of Legal Affairs & Legal Affairs - South Asia 1955
Ms. Aparna Thomas Sr. Director of Corp. Communications & CSR, India & South Asia 1975
Mr. Gaurav Bahadur Sr. Director of HR - India & South Asia 1970
Dr. Goel Devendrakumar B.V.Sc.&A.H. Head of Sri Lanka Operations 1953
Mr. Sanjay V. Chavan Head of Country Procurement - India 1962

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.